ReviewInternational journal of molecular sciences2019

Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers.

Kaye J Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.